Anti-malaria drug hydroxychloroquine’s coronavirus trials to resume, says WHO
  • 4 years ago
Anti-malaria drug hydroxychloroquine will be once again tested for its effectiveness against the novel coronavirus as the World Health Organization has decided to resume its trials under the Solidarity Trials.
Recommended